Publications by authors named "Aleksandra Paduszynska"

Article Synopsis
  • * Involving 8,667 patients and 862 physicians, the study found significant improvements after 3 months, including reduced body weight, lower blood pressure, and decreased cholesterol levels, alongside increased patient compliance and satisfaction.
  • * The study concluded that tailored health education on lifestyle changes can effectively reduce cardiovascular disease risk factors and enhance treatment outcomes, emphasizing the need for ongoing, personalized health advice during regular check-ups.
View Article and Find Full Text PDF

Introduction: In women, an increase in blood pressure is observed after the menopause. However, the confounding effect of aging and comorbidities should be taken into account. Current guidelines don't recommend any specific treatment of post-menopausal hypertension.

View Article and Find Full Text PDF

Background: Adipose tissue is producing adipokines that play different roles in the pathophysiology of cardiovascular disease.

Aims: The study aimed to assess the role of selected biomarkers in hypertensive patients with overweight and obesity compared with those with normal body-mass index (BMI).

Methods: A total of 62 patients with BMI < 25 kg/m (median age 54 (46-58) yrs.

View Article and Find Full Text PDF

Cardiogenic strokes comprised 11% of all strokes and 25% of ischemic strokes. An accurate identification of the cause of stroke is necessary in order to prepare an adequate preventive strategy. In this review the confirmed and potential causes of embolic strokes are presented, which can be detected in echocardiography in the context of present treatment guidelines and gaps in evidence.

View Article and Find Full Text PDF

Introduction: Neuronal nicotinic acetylcholine receptors are ligand-gated ion channel receptors, distributed throughout central nervous system, as well as in peripheral ganglia and some non-neuronal cells. Cytisine, a qulinolizidine alkaloid, could be considered a high affinity ligand of those receptors. It is a partial agonist of β2*-containing receptors and a full agonist of α7 and β4*-containing receptors.

View Article and Find Full Text PDF